Randomised Phase II trial of irinotecan with hyaluronic acid (HyCAMP) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU based chemotherapy (CTA 2004) ............incidence of grade 3 or 4 diarrhoea.
100 项与 Meditech Research Ltd. 相关的临床结果
0 项与 Meditech Research Ltd. 相关的专利(医药)
100 项与 Meditech Research Ltd. 相关的药物交易
100 项与 Meditech Research Ltd. 相关的转化医学